Read + Share
Yamakawa K, Ogata D, Hiki K, Jinnai S, et al. Metastatic basal cell carcinoma with a high tumor mutational burden that achieved
complete response with pembrolizumab. Int J Dermatol 2022 May 12. doi: 10.1111/ijd.16245.
PMID: 35553058
|
 |
|
Yamakawa K, Ogata D, Hiki K, Jinnai S, et al. Metastatic basal cell carcinoma with a high tumor mutational burden that achieved
complete response with pembrolizumab. Int J Dermatol 2022 May 12. doi: 10.1111/ijd.16245.
PMID: 35553058
|
|
|
|